Effects of staged versus ad hoc percutaneous coronary interventions on renal function—Is there a benefit to staging?
Mahek Shah(Lehigh Valley Hospital-Pocono), Janani Rangaswami(George Washington University), David Wheeler(Einstein Medical Center Philadelphia), Obiora Maludum(Einstein Medical Center Philadelphia), Amer Ardati(University of Illinois Chicago), Christian Witzke(Einstein Medical Center Philadelphia), Kenechukwu Mezue(University of the Commonwealth Caribbean), Deepakraj Gajanana(Einstein Medical Center Philadelphia), Edgar V. Lerma, Abel Romero‐Corral(Mayo Clinic), Chitra Punjabi(Einstein Medical Center Philadelphia)
Cited by 16
Related Papers
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
Interactions Between Obesity and Obstructive Sleep Apnea
|CHEST Journal|2010|765